Cargando…
SELDI蛋白质指纹对因基因多态性导致耐药性漂移诊断的前瞻性研究——吉非替尼与含铂方案序贯治疗非小细胞肺癌
BACKGROUND AND OBJECTIVE: This study aims to observe the long-term effects of sequential therapy with a platinum-based regimen and gefitinib for non-small cell lung carcinoma (NSCLC) with failed chemotherapy under the guidance of surface-enhanced laser desorption/ionization (SELDI). METHODS: Nine NS...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000459/ https://www.ncbi.nlm.nih.gov/pubmed/23327871 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.01.06 |
Ejemplares similares
-
ERCC1基因多态性与晚期非小细胞肺癌患者铂类化疗疗效的关系
Publicado: (2010) -
XRCC1和XRCC3单核苷酸多态性与晚期非小细胞肺癌铂类药物化疗疗效的相关性
Publicado: (2011) -
替吉奥胶囊导致的急性间质性肺病1例报道
Publicado: (2014) -
EGFR基因rs2293347多态对吉非替尼治疗非小细胞肺癌临床疗效的影响
Publicado: (2011) -
肺腺癌吉非替尼获得性耐药相关microRNAs的筛选鉴定
Publicado: (2011)